Literature DB >> 2181155

Neurodegenerative disease induced by the wild mouse ecotropic retrovirus is markedly accelerated by long terminal repeat and gag-pol sequences from nondefective Friend murine leukemia virus.

J L Portis1, S Czub, C F Garon, F J McAtee.   

Abstract

The wild mouse ecotropic retrovirus (WM-E) induces a spongiform neurodegenerative disease in mice after a variable incubation period of 2 months to as long as 1 year. We isolated a molecular clone of WM-E (15-1) which was weakly neurovirulent (incidence, 8%) but was highly leukemogenic (incidence, 45%). Both lymphoid and granulocytic leukemias were observed, and these leukemias were often neuroinvasive. A chimeric virus was constructed containing the env and 3' pol sequences of 15-1 and long terminal repeat (LTR), gag, and 5' pol sequences from a clone of Friend murine leukemia virus (FB29). FB29 has been shown previously to replicate to high levels in the central nervous system (CNS) but is not itself neurovirulent. This finding was confirmed at the DNA level in the current study. Surprisingly, intraperitoneal inoculation of neonatal IRW mice with the chimeric virus (FrCasE) caused an accelerated neurodegenerative disease with an incubation period of only 16 days and was uniformly fatal by 23 days postinoculation. Introduction of the LTR of 15-1 into the FrCasE genome yielded a virus (FrCasEL) with a degree of neurovirulence intermediate between those of 15-1 and FrCasE. No differences were found in the levels of viremia or the relative levels of viral DNA in the spleens of mice inoculated with 15-1, FrCasE, or FrCasEL. However, the levels of viral DNA in the CNS correlated with the relative degrees of neurovirulence of the respective viruses (FrCasE greater than FrCasEL greater than 15-1). Thus, the env and 3' pol sequences of WM-E (15-1) were required for neurovirulence, but elements within the LTR and gag-pol regions of FB29 had a profound influence on the level of CNS infection and the rate of development of neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2181155      PMCID: PMC249301          DOI: 10.1128/JVI.64.4.1648-1656.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  A major genetic locus affecting resistance to infection with murine leukemia viruses. IV. Dose-response relationships in Fv-1-sensitive and resistant cell cultures.

Authors:  T Pincus; J W Hartley; W P Rowe
Journal:  Virology       Date:  1975-06       Impact factor: 3.616

2.  Clonal heterogeneity of wild mouse leukemia viruses: host ranges and antigenicity.

Authors:  M L Bryant; V Klement
Journal:  Virology       Date:  1976-09       Impact factor: 3.616

Review 3.  Wild mouse retrovirus: pathogenesis.

Authors:  J L Portis
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

4.  Murine neurotropic retrovirus spongiform polioencephalomyelopathy: acceleration of disease by virus inoculum concentration.

Authors:  B R Brooks; J R Swarz; O Narayan; R T Johnson
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

5.  Lower motor neuron degeneration associated with type C RNA virus infection in mice: neuropathological features.

Authors:  J M Andrews; M B Gardner
Journal:  J Neuropathol Exp Neurol       Date:  1974-04       Impact factor: 3.685

6.  Spontaneous tumors of aging wild house mice. Incidence, pathology, and C-type virus expression.

Authors:  M B Gardner; B E Henderson; R W Rongey; J D Estes; R J Huebner
Journal:  J Natl Cancer Inst       Date:  1973-03       Impact factor: 13.506

7.  Thrombocytopenia induced by the Friend leukemia virus.

Authors:  L H Dennis; I Brodsky
Journal:  J Natl Cancer Inst       Date:  1965-12       Impact factor: 13.506

8.  Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: friend-specific and FMR-specific antigens.

Authors:  B Chesebro; K Wehrly; M Cloyd; W Britt; J Portis; J Collins; J Nishio
Journal:  Virology       Date:  1981-07-15       Impact factor: 3.616

9.  Akvr-1, a dominant murine leukemia virus restriction gene, is polymorphic in leukemia-prone wild mice.

Authors:  M B Gardner; S Rasheed; B K Pal; J D Estes; S J O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

10.  Genomes of murine leukemia viruses isolated from wild mice.

Authors:  S K Chattopadhyay; A I Oliff; D L Linemeyer; M R Lander; D R Lowy
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

View more
  59 in total

1.  Neural stem cells as engraftable packaging lines can mediate gene delivery to microglia: evidence from studying retroviral env-related neurodegeneration.

Authors:  W P Lynch; A H Sharpe; E Y Snyder
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Capillary endothelial cell tropism of PVC-211 murine leukemia virus and its application for gene transduction.

Authors:  M Masuda; C A Hanson; N V Dugger; D S Robbins; S G Wilt; S K Ruscetti; P M Hoffman
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  The R-U5-5' leader sequence of neurovirulent wild mouse retrovirus contains an element controlling the incubation period of neurodegenerative disease.

Authors:  J L Portis; S Perryman; F J McAtee
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

4.  Long-lasting protective antiviral immunity induced by passive immunotherapies requires both neutralizing and effector functions of the administered monoclonal antibody.

Authors:  Roudaina Nasser; Mireia Pelegrin; Henri-Alexandre Michaud; Marc Plays; Marc Piechaczyk; Laurent Gros
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

5.  Brain infection by neuroinvasive but avirulent murine oncornaviruses.

Authors:  S Asković; F J McAtee; C Favara; J L Portis
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Induction of long-term protective antiviral endogenous immune response by short neutralizing monoclonal antibody treatment.

Authors:  Laurent Gros; Hanna Dreja; Anne Laure Fiser; Marc Plays; Mireia Pelegrin; Marc Piechaczyk
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

7.  Monoclonal antibody 667 recognizes the variable region A motif of the ecotropic retrovirus CasBrE envelope glycoprotein and inhibits Env binding to the viral receptor.

Authors:  Hanna Dreja; Laurent Gros; Sylvie Villard; Estanislao Bachrach; Anna Oates; Claude Granier; Thierry Chardes; Jean-Claude Mani; Marc Piechaczyk; Mireia Pelegrin
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Inhibition of murine retrovirus-induced neurodegeneration in the spinal cord by explant culture.

Authors:  R A Bessen; W P Lynch; J L Portis
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Identification of a sequence in the unique 5' open reading frame of the gene encoding glycosylated Gag which influences the incubation period of neurodegenerative disease induced by a murine retrovirus.

Authors:  J L Portis; G J Spangrude; F J McAtee
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

Review 10.  Innate immunity in the pathogenesis of polytropic retrovirus infection in the central nervous system.

Authors:  Karin E Peterson; Min Du
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.